A customer in her late fifties stops at the CoQ10 bay with her phone out. An AI assistant has just told her about mitochondria, cellular energy and something called healthspan, and it mentioned ubiquinol by name. Her question is simple: which of these bottles should she buy, and is the expensive one worth it?
More shoppers will arrive with that question this fall. Kaneka Ubiquinol has been named Healthspan Ingredient of the Year at the NutraIngredients-Asia Awards, and the recognition gives Canadian health retailers a timely reason to talk about CoQ10. The catch is that a Canadian label can only promise what ordinary CoQ10 already promises, while the ubiquinol form costs about two and a half times as much per milligram. Stores that turn this award into sales will be the ones whose staff can tell the story in the words Health Canada allows and explain the price difference honestly.
What the award is worth at the counter
The ceremony took place in Bangkok on September 2, with a record 256 entries across the program. It is the ingredient’s third consecutive recognition from these awards, following a healthy ageing win in 2024 and a women’s health shortlisting in 2025. Kaneka counts it as its seventh international honour. According to publisher Gary Scattergood, the judges were impressed by the scientific evidence behind ubiquinol and by “significant evidence of commercial success across the region.”
For a buyer, that combination is the useful part. An independent panel reviewed both the research file and the sales record, which makes ubiquinol a lower-risk listing and gives staff a credible reply when a customer wonders whether it is a passing fad.
Kaneka is also using the moment to promote “mitoceuticals,” its term for nutraceuticals formulated to support mitochondrial function. Ubiquinol, the reduced form of coenzyme Q10 that cells use in energy production, sits at the centre of that idea. To make the point, the company’s release cites an eLife study estimating more than 5,000 mitochondria in every heart cell. Kaneka describes itself as the sole global manufacturer of ubiquinol. Even so, a March 2026 trial in Clinical Pharmacology in Drug Development tested a ubiquinol cocrystal from a Chinese developer. Suppliers should be able to say whose raw material is in their product, since research on one source does not automatically transfer to another.
The raw material itself usually travels as a powder. Alongside its standard ingredient, Kaneka supplies an air-stable ubiquinol powder, Kaneka Q30, which it says suits capsules, stick packs, powdered beverages and nutrition bars, and its product developers work in formats from gummies to fast-dissolving powders. For the shelf, that means one ingredient can arrive in several forms, and the format a customer prefers is as much a reason to choose a product as the ingredient inside it.
Demand at home is real. A Global Burden of Disease analysis published this summer in The Lancet Public Health measured the gap between lifespan and years lived in good health. Worldwide, it reached 10.7 years in 2023, up from 8.8 in 1990. Canada’s gap was wider still, at 13.7 years. People facing that prospect are looking for ways to stay well for longer, and many of them are already in the aisle.
Telling the story the Canadian way
None of the award’s vocabulary appears on a Canadian label. Health Canada’s Coenzyme Q10 monograph, revised on January 31, 2025, names ubiquinone-10 and allows three kinds of claim: support for cardiovascular health, antioxidant protection, and fewer migraine headaches when taken preventively. Ubiquinol products are licensed here too, and they use the same language. Natural Factors’ Ubiquinol Active CoQ10, which contains Kaneka’s ingredient, says it “helps support cardiovascular health” and “provides antioxidants for the maintenance of good health.”
Those words matter beyond the bottle, because Canada’s consumer advertising guidelines for health products treat in-store promotional material as advertising. A retailer may paraphrase a product’s approved claims but cannot go beyond them. Awards and seals from recognized organizations are acceptable as long as the claims beside them stay within the licence and the advertiser can document the recognition. A shelf-talker reading “Award-winning Kaneka ubiquinol. Helps support cardiovascular health and provides antioxidants” meets that standard, provided a copy of the award announcement is kept on file. “Cellular energy for healthy ageing” would not.
One line from Kaneka’s release should stay off the shop floor entirely. The company describes ubiquinol as supporting health “from preconception to healthy ageing,” yet every CoQ10 product sold under the monograph must tell pregnant and breastfeeding customers to speak with a practitioner first. Ubiquinol therefore belongs nowhere near a fertility or prenatal display.
Which bottle she should take home
Back at the bay, the price difference is the first thing she notices. Here is how it looked at Nutrition House’s Canadian online store on September 16:
| Product | Form | Price | Cost per 100 mg |
|---|---|---|---|
| Natural Factors, 100 mg, 120 softgels | Ubiquinol | $74.95 | about 62 cents |
| Preferred Nutrition, 150 mg, 180 softgels | Ubiquinone | $61.97 | about 23 cents |
| NOW, 400 mg, 60 softgels | Ubiquinone | $62.29 | about 26 cents |
Absorption accounts for part of that gap. In the comparison most often cited, a 2014 study by Peter and Alena Langsjoen, 12 healthy volunteers took 200 mg a day of each form for four weeks. Blood CoQ10 rose from 0.9 to 2.5 µg/mL with ubiquinone and from 0.9 to 4.3 µg/mL with ubiquinol, a gain slightly more than twice as large.
At that dose, ubiquinol costs about $1.25 a day and raised blood levels by 3.4 units, or 37 cents per unit. Ubiquinone costs about 46 cents a day for a rise of 1.6 units, which works out to 29 cents per unit. These figures are illustrative, drawn from one retailer’s prices and one small open-label study with no placebo group, and they assume absorption behaves the same way at other doses. A blood level is also not a health outcome.
What emerges is a natural two-tier shelf. Ubiquinone is the value option and still delivers blood CoQ10 slightly more cheaply. Ubiquinol is the convenience option, reaching a higher level from fewer servings, which appeals to customers who dislike taking several capsules a day. Showing cost per 100 mg on both tags lets her make that choice herself, and those who trade up bring a larger ticket and more margin dollars without feeling pushed. The 2026 cocrystal study also reported roughly double the exposure, but its results apply only to that formulation and should not be quoted for other brands.
Beyond the CoQ10 bay
The Lancet study also shows where the rest of her basket could come from. Musculoskeletal disorders, depression and anxiety, hearing loss and falls account for more than half of the world’s unhealthy years, and none of them is a CoQ10 claim. A healthy-ageing destination built on that evidence groups products by approved need-states such as joints, bone, sleep, mood and heart. CoQ10 sits in the heart section beside other cardiovascular products, many omega-3 formulas among them. The neighbouring sections give staff an easy next conversation once the first purchase is settled. An award that brought one customer to one bottle can end in a basket that covers several of the years she hopes to keep healthy.
Frequently Asked Questions
Which other cautions must a CoQ10 product carry in Canada?
Beyond the pregnancy and breastfeeding warning, every product under Health Canada’s January 2025 monograph must advise consulting a practitioner before use with blood pressure medication. Products supplying more than 100 mg a day must also caution people taking blood thinners, a threshold most ubiquinol softgels pass at their upper recommended dose.
What dose does Health Canada allow for the CoQ10 migraine claim?
Adults may take 150 to 300 mg a day preventively, and the label must direct use for at least three months before judging the effect. The cardiovascular claim covers 30 to 300 mg a day, and antioxidant claims cap at 300 mg. A 100 mg softgel therefore needs at least two daily servings to carry the migraine claim.
How can a retailer check exactly what a CoQ10 product is allowed to claim?
Search the product’s eight-digit NPN in Health Canada’s Licensed Natural Health Products Database, which shows the recommended use, dose and cautions on the licence. Natural Factors Ubiquinol CoQ10 100 mg, for example, is listed by Canadian retailers under NPN 80028985. Signage and website copy should follow that record rather than supplier sales sheets.
Do women and men face the same healthspan gap?
No. The Lancet Public Health analysis found that women spend an average of 12.1 years in poor health, compared with 9.3 years for men, despite living longer. For a healthy-ageing set, that makes women over 50 the larger share of demand, which argues for giving bone, joint and mood products as much space as heart health.
This is independent editorial analysis by IHR Magazine. It references Kaneka Ubiquinol as one example of the mitochondrial health trend and is not an endorsement of any product or supplier. Retailers should verify each product’s NPN and licensed claims before merchandising. Prices were recorded on September 16, 2026, and will change.
